Genome-wide combination profiling of copy number and methylation offers an approach for deciphering misregulation and development in cancer cells

Gene

Volumn 407, Issue 1-2, 2008, Pages 139-147

  Park, Jung Jun ^a   Kang, Jae Ku ^a   Hong, Su ^a   Ryu, Eun Sook ^a   Kim, Jong Il ^b   Lee, Jong Ho ^a   Seo, Jeong Sun ^a,b  

^a Macrogen Inc   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

BAC microarray; Copy number change; DNA methylation; Genetic and epigenetic relationship

Indexed keywords

BIOLOGICAL MARKER;

ANALYTIC METHOD; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE REGULATION; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CLONE; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; FHIT GENE; GENE CONTROL; GENOME ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MAMMAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GENE; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

MAMMALIA;

EID: 37049020657     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2007.10.011     Document Type: Article

References (54)

1. Ando Y., and Hayashizaki Y. Restriction landmark genomic scanning. Nat. Protoc. 1 (2006) 2774-2783
2. Baylin S.B., Belinsky S.A., and Herman J.G. Aberrant methylation of gene promoters in cancer-concepts, misconcepts, and promise. J. Natl. Cancer Inst. 20 (2000) 1460-1461
3. Ching T.T., et al. Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3. Nat. Genet. 37 (2005) 645-651
4. Chen J.M., Stenson P.D., Cooper D.N., and Ferec C. A systematic analysis of LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease. Hum. Genet. 117 (2005) 411-427
5. Cho Y.L., et al. Array comparative genomic hybridization analysis of uterine leiomyosarcoma. Gynecol. Oncol. 99 (2005) 541-551
6. Eden A., Gaudet F., Waghmare A., and Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300 (2003) 455
7. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 21 (2002) 5400-5413
8. Ehrlich M. Cancer-linked DNA hypomethylation and its relationship to hypermethylation. Curr. Top. Microbiol. Immunol. 310 (2006) 251-274
9. Esteller M., and Herman J.G. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J. Pathol. 196 (2002) 1-7
10. Florl A.R., et al. Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation. Br. J. Cancer 91 (2004) 985-994
11. Foja S., Goldberg M., Schagdarsurengin U., Dammann R., Tannapfel A., and Ballhausen W.G. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas. Liver Int. 25 (2005) 1202-1208
12. Fong K.M., et al. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res. 57 (1997) 2256-2267
13. Fruhwald M.C., and Plass C. Global and gene-specific methylation patterns in cancer: aspects of tumor biology and clinical potential. Mol. Genet. Metab. 75 (2002) 1-16
14. Gilbert N., Lutz S., Morrish T.A., and Moran J.V. Multiple fates of L1 retrotransposition intermediates in cultured human cells. Mol. Cell. Biol. 25 (2005) 7780-7795
15. Gitan R.S., Shi H., Chen C.M., Yan P.S., and Huang T.H. Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. Genome Res. 12 (2002) 158-164
16. Hirsch F., et al. Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib. Ann. Oncol. 18 (2007) 752-760
17. Hori T.A. Induction of chromosome decondensation, sister-chromatid exchanges and endoreduplications by 5-azacytidine, an inhibitor of DNA methylation. Mutat. Res. 121 (1983) 47-52
18. Hu M., et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat. Genet. 37 (2005) 899-905
19. Huang L.W., Chao S.L., and Chen T.J. Reduced Fhit expression in cervical carcinoma: correlation with tumor progression and poor prognosis. Gynecol. Oncol. 90 (2003) 331-337
20. Ishii H., et al. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies. Mol. Cancer Res. 1 (2003) 940-947
21. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
22. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3 (2002) 415-428
23. Jones P.A., and Laird P.W. Cancer epigenetics comes of age. Nat. Genet. 21 (1999) 163-167
24. Karpinets T.V., and Foy B.D. Tumorigenesis: the adaptation of mammalian cells to sustained stress environment by epigenetic alterations and succeeding matched mutations. Carcinogenesis 26 (2005) 1323-1334
25. Khulan B., et al. Comparative isoschizomer profiling of cytosine methylation: The HELP assay. Genome Res. 16 (2006) 1046-1055
26. Malkhosyan S., Yasuda J., Soto J.L., Sekiya T., Yokota J., and Perucho M. Molecular karyotype (amplotype) of metastatic colorectal cancer by unbiased arbitrarily primed PCR DNA fingerprinting. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 10170-10175
27. Menendez L., Benigno B.B., and McDonald J.F. L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas. Mol. Cancer 3 (2004) 12
28. Michael D., Beer D.G., Wilke C.W., Miller D.E., and Glover T.W. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas. Oncogene 15 (1997) 1653-1659
29. Nishigaki M., et al. Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays. Cancer Res. 65 (2005) 2115-2124
30. Nygren A.O., et al. Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res. 16 (2005) e128
31. Negrini M., et al. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res. 56 (1996) 3173-3179
32. Olejniczak E.T., et al. Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains. Mol. Cancer Res. 5 (2007) 331-339
33. Park S.J., Jeong S.Y., and Kim H.J. Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array. Cancer Genet. Cytogenet. 166 (2006) 56-64
34. Ragoussis J., Elvidge G.P., Kaur K., and Colellar S. Matrix-assisted laser desorption/ionisation, time-of-flight mass spectrometry in genomics research. PLoS Genet. 2 (2006) 920-929
35. Robertson K.D. DNA methylation, methyltransferases, and cancer. Oncogene 28 (2001) 3139-3155
36. Rodenhiser D., and Mann M. Epigenetics and human disease: translating basic biology into clinical applications. CMAJ 174 (2006) 341-348
37. Saito S., Ghosh M., Morita K., Hirano T., Miwa M., and Todoroki T. The genetic differences between gallbladder and bile duct cancer cell lines. Oncol. Rep. 16 (2006) 949-956
38. Santini V., Kantarjian H.M., and Issa J.P. Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann. Intern. Med. 134 (2001) 573-586
39. Schulz W.A., et al. Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma. Genes Chromosomes Cancer 35 (2002) 58-65
40. Schumacher A., et al. Microarray-based DNA methylation profiling: technology and applications. Nucleic Acids Res. 34 (2006) 528-542
41. Shi H., et al. Expressed CpG island sequence tag microarray for dual screening of DNA hypermethylation and gene silencing in cancer cells. Cancer Res. 62 (2002) 3214-3220
42. Suzuki K., et al. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 9 (2006) 199-207
43. Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J. Gastroenterol. 12 (2006) 192-198
44. Tollefsbol T.O. Methods of epigenetic analysis. Methods Mol. Biol. 287 (2004) 1-8
45. Tzao C., Tsai H.Y., Chen J.T., Chen C.Y., and Wang Y.C. 5'CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancer. Eur. J. Cancer 40 (2004) 2175-2183
46. Virgilio L., et al. FHIT gene alterations in head and neck squamous cell carcinomas. Proc. Natl. Acad. Sci. U. S. A 93 (1996) 9770-9775
47. Wang Y., et al. "Promoter array" studies identify cohorts of genes directly regulated by methylation, copy number change, or transcription factor binding in human cancer cells. Ann. N.Y. Acad. Sci. 1058 (2005) 162-185
48. Weber M., et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 37 (2005) 853-862
49. Weisenberger D.J., et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res. 33 (2005) 6823-6836
50. Wilson I.M., et al. Epigenomics: mapping the methylome. Cell Cycle 5 (2006) 155-158
51. Xiao G.H., Jin F., Klein-Szanto A.J., Goodrow T.L., Linehan M.W., and Yeung R.S. The FHIT gene product is highly expressed in the cytoplasm of renal tubular epithelium and is down-regulated in kidney cancers. Am. J. Pathol. 151 (1997) 1541-1547
52. Yamamoto F., and Yamamoto M. A DNA microarray-based methylation-sensitive (MS)-AFLP hybridization method for genetic and epigenetic analyses. Mol. Genet. Genomics 271 (2004) 678-686
53. Yan P.S., et al. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Res. 61 (2001) 8375-8380
54. Yang Q., et al. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer. Clin. Cancer Res. 8 (2002) 2890-2893